News
The researchers found that from 2010 to 2023, there was an increase in the percentage of the T1D population prescribed GLP-1 RAs from 0.3 to 6.6%, while SGLT2 inhibitor prescribing increased from ...
12d
MedPage Today on MSNNew Guideline Puts Some at the Front of the Line for GLP-1, SGLT2 Drugs
No blanket recommendation can be made for SGLT2 inhibitors and GLP-1 receptor agonists in adults with type 2 diabetes (T2D) ...
They compared patients prescribed GLP-1-RAs or SGLT2 inhibitors with 68,400 patients prescribed DPP-4 inhibitors, which previous studies suggest do not increase ARD risk.
SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher ...
Compared with the general type 1 diabetes population, those newly prescribed a GLP-1 agonist or SGLT2 inhibitor tended to be older (41.5 vs 47.1 vs 56.8 years, respectively).
Of those who were not using SGLT2 inhibitors at baseline, 290 of 1490 (19.5%) treated with semaglutide vs 372 of 1493 (24.9%) receiving placebo had the kidney composite outcome (HR, 0.73; P < .001).
GLP-1 receptor agonists may reduce cancer risk among people with obesity or overweight, according to retrospective study results.Adults who used GLP-1 medications exhibited a statistically significant ...
Within the subclass of GLP-1 RAs, semaglutide increased the most, from 0.2% to 4.4% from 2018 to 2023. Within 1 year, tirzepatide, which was approved in 2022, reached 1.3%.
GLP-1 RAs, SGLT2 Inhibitors May Reduce Risk for Alzheimer Disease, Dementia in T2DM April 18, 2025 ...
Investigators also pointed out SGLT2 inhibitors had a greater proportion of users with any albuminuria (31.3% or heart failure (6.3% vs 0%) than GLP-1 receptor agonist users.
Fewer than one in 10 adults with type 2 diabetes in the U.S. use SGLT2 inhibitors or GLP-1 receptor agonists, and only SGLT2 inhibitors have seen an increase in use over the last decade, according ...
GLP-1 receptor (GLP-1R) agonists and DPP-4 inhibitors increase natriuresis in T2DM, possibly through overlapping and distinct mechanisms, and might slightly improve renal haemodynamics in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results